CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer

Abstract

BACKGROUND Considering neoadjuvant chemotherapy (NAC) prior to surgery could shrink and reduce the primary tumor and distant micro-metastases to reduce the high relapses rates, NAC has been an accepted therapeutic management for patients with non-small cell lung cancer (NSCLC). CMTM1_v17 is highly expressed in human testis tissues and solid tumor tissues… (More)
DOI: 10.1186/s12957-016-1094-z

11 Figures and Tables

Topics

  • Presentations referencing similar topics